CSIMarket
 
Takeda Pharmaceutical Company Limited  (TAK)
Other Ticker:  
 
 
Price: $14.4700 $0.13 0.907%
Day's High: $14.51 Week Perf: -0.69 %
Day's Low: $ 14.34 30 Day Perf: -0.48 %
Volume (M): 2,317 52 Wk High: $ 17.15
Volume (M$): $ 33,523 52 Wk Avg: $15.23
Open: $14.37 52 Wk Low: $13.19



 Market Capitalization (Millions $) 22,716
 Shares Outstanding (Millions) 1,570
 Employees -
 Revenues (TTM) (Millions $) 27,902
 Net Income (TTM) (Millions $) 2,196
 Cash Flow (TTM) (Millions $) 5,887
 Capital Exp. (TTM) (Millions $) 974

Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is a renowned global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1781, it has a rich history of more than 230 years in the healthcare industry. Takeda operates with a mission to provide better health and brighter future for people worldwide through innovative and high-quality pharmaceutical products.

The company specializes in various therapeutic areas including oncology, gastroenterology, neuroscience, rare diseases, and vaccines. Takeda focuses on research and development (R&D) to discover and develop innovative medicines that address unmet medical needs and improve patient outcomes. They have a strong pipeline of promising drug candidates under development.

Takeda has a significant global presence, with operations in around 80 countries and regions. They collaborate with partners, healthcare professionals, and patient communities to deliver their products to patients in need across the globe. The company maintains a strong commitment to diversity and inclusion, environmental sustainability, and corporate social responsibility.

With a workforce of over 50,000 employees, Takeda continues to play a vital role in the pharmaceutical industry, constantly striving to improve healthcare and contribute to the well-being of people worldwide.


   Company Address: 1-1, Nihonbashi-Honcho 2-Chome Tokyo 103
   Company Phone Number: 3 3278-2306   Stock Exchange / Ticker: NYSE TAK
   TAK is expected to report next financial results on June 27, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals Witnesses an Impressive $27.9 Trillion Revenue in the Latest Fiscal Period

In recent financial reports, Takeda Pharmaceutical Company Limited has revealed seemingly impressive figures, with a reported revenue of $27.90 billion and net profits of $2.20 billion for the fiscal year 2023. However, a closer analysis of these numbers uncovers several concerning trends and factors that suggest a bearish outlook for the company.
Firstly, while the company boasted a 30.34% increase in net profits compared to the previous year, it's important to note that this growth was achieved from a relatively low base. The net earnings of $1,685.111 million reported in the fiscal span ending March 31, 2022, were already lower than expected, indicating a decline in profitability. Therefore, the recent increase in net profits may not be sustainable and could simply be a rebound from a low point.






 

Takeda Pharmaceutical Limited's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com